Clinical consensus statements on patients with chronic coronary syndromes.

29 August 2022 (17:06 - 17:18)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)

4 More presentations in this session

Presentation thumbnail

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease - Introduction.

Professor D. Capodanno (Catania, IT)

Presentation thumbnail

Short- and long-term efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: results of two network meta-analyses

Professor E. Navarese (Sassari, IT)

Presentation thumbnail

Clinical consensus statements on patients with acute coronary syndromes patients.

Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Presentation thumbnail

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease - Q&A and panel discussion.

Access the full session

Session thumbnail

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

The Event

Event poster

ESC Congress 2022

29 August 2022 17:06 CET

You may be interested in

Congress Presentation

Anticoagulant therapy for chronic coronary syndromes: in which direction is the compass pointing?

26 August 2022

Congress Presentation

Initial and long-term guideline-directed medical therapy of chronic coronary syndromes: a comprehensive approach

31 August 2024

Congress Presentation

Antiplatelet regimens and beyond in acute coronary syndromes: Role of lipid lowering, P2 Y12 monotherapy and more.

27 August 2022

Congress Presentation

Antiplatelet agents for chronic coronary syndromes: which ones and for whom?

26 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources